Praxis Precision Medicines (PRAX) 8-K Summary

Filing Date: November 5, 2025

• Material Event: The Company furnished its financial results press release for the quarter ended September 30, 2025 under Item 2.02.
• Investor Action: Full financial performance metrics and guidance are located in Exhibit 99.1.
• Disclaimer: Information furnished via Item 2.02/Exhibit 99.1 is not deemed filed for liability purposes under Section 18 of the Exchange Act.

Critical Note: This 8-K serves only as the notification vehicle; investors must review the linked press rel